THIS IS HUGE! An HIV PrEP drug candidate in the form of a twice-yearly subcutaneous injection has been shown to reduce HIV infections by 96% in a SECOND late-stage Phase III trial. Lenacapavir was 99.9% effective at preventing HIV in MORE THAN 2,000 participants. Let’s talk about that! 🧪🧵⬇️

To those who are scared, this is not an end game. There are still many MANY opportunities for us to engage, fight small battles, and tackle the issues. Depending on where you live, that battle will be more uphill than others. This moment further emphasizes the need to organize 1/3

thank you blue sky bridge for helping us connect with our mutuals again… i hope everyone has a great day…